19
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

SYNTHESIS AND BIOLOGICAL EVALUATION OF 1,2,3-THIA AND SELENADIAZOLES-4-DERIVATIVES

, , &
Pages 155-163 | Received 10 Aug 1995, Accepted 15 Jan 1996, Published online: 04 Oct 2006
 

Abstract

Visnagin-9-sulfonyl chloride (Ic) reacted with p-aminoacetophenone to give visnagin-9-N-(p-acetophenyl) sulfonamide (II), which in turn was reacted with semicarbazide hydrochloride in the presence of sodium acetate to give the corresponding visnagin-9-N-(p-acetophenyl semicarbazone) sulfonamide (IV). The latter compound was cyclized through oxidation with thionyl chloride to yield 1,2,3-thiadiazol-4derivative (V), while the oxidative cyclization with selenium dioxide led to the formation of 1,2,3-selenadiazol-4-derivative (VI). Visnaginone (VIIa) or khellinone (VIIb) was reacted with p-aminoacetophenone in absolute ethanol to give the Schiff's bases (VIIIa,b), respectively. The latter compounds were condensed with semicarbazide hydrochloride to yield the corresponding semicarbazone derivatives (IXa,b), respectively. The oxidative cyclization of IXa or IXb using thionyl chloride gave 1,2,3-thiadiazol-4-derivatives (Xa) and (Xc), while the oxidative cyclization of IXa or IXb using selenium dioxide gave 1,2,3-selenadiazol-4-derivatives (Xb) and (Xd), respectively. The antimicrobial and antiaflatoxigenic activities of thia and selenadiazoles were also investigated.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.